» Articles » PMID: 33525637

Functional Genomics Approaches to Elucidate Vulnerabilities of Intrinsic and Acquired Chemotherapy Resistance

Overview
Journal Cells
Publisher MDPI
Date 2021 Feb 2
PMID 33525637
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Drug resistance is a commonly unavoidable consequence of cancer treatment that results in therapy failure and disease relapse. Intrinsic (pre-existing) or acquired resistance mechanisms can be drug-specific or be applicable to multiple drugs, resulting in multidrug resistance. The presence of drug resistance is, however, tightly coupled to changes in cellular homeostasis, which can lead to resistance-coupled vulnerabilities. Unbiased gene perturbations through RNAi and CRISPR technologies are invaluable tools to establish genotype-to-phenotype relationships at the genome scale. Moreover, their application to cancer cell lines can uncover new vulnerabilities that are associated with resistance mechanisms. Here, we discuss targeted and unbiased RNAi and CRISPR efforts in the discovery of drug resistance mechanisms by focusing on first-in-line chemotherapy and their enforced vulnerabilities, and we present a view forward on which measures should be taken to accelerate their clinical translation.

Citing Articles

RAD54L2 counters TOP2-DNA adducts to promote genome stability.

DAlessandro G, Morales-Juarez D, Richards S, Nitiss K, Serrano-Benitez A, Wang J Sci Adv. 2023; 9(49):eadl2108.

PMID: 38055822 PMC: 10699776. DOI: 10.1126/sciadv.adl2108.


Virtual screening reveals aprepitant to be a potent inhibitor of neutral sphingomyelinase 2: implications in blockade of exosome release in cancer therapy.

Moloudizargari M, Hekmatirad S, Gharaghani S, Moghadamnia A, Najafzadehvarzi H, Asghari M J Cancer Res Clin Oncol. 2023; 149(10):7207-7216.

PMID: 36884117 DOI: 10.1007/s00432-023-04674-6.

References
1.
Dijt F, Berends F, Reedijk J . Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts. Cancer Res. 1988; 48(21):6058-62. View

2.
Kim D, Rossi J . RNAi mechanisms and applications. Biotechniques. 2008; 44(5):613-6. PMC: 2727154. DOI: 10.2144/000112792. View

3.
Yang H, Villani R, Wang H, Simpson M, Roberts M, Tang M . The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res. 2018; 37(1):266. PMC: 6211502. DOI: 10.1186/s13046-018-0909-x. View

4.
Pommier Y, Leo E, Zhang H, Marchand C . DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol. 2010; 17(5):421-33. PMC: 7316379. DOI: 10.1016/j.chembiol.2010.04.012. View

5.
Guerreiro A, Fattet S, Kulesza D, Atamer A, Elsing A, Shalaby T . A sensitized RNA interference screen identifies a novel role for the PI3K p110γ isoform in medulloblastoma cell proliferation and chemoresistance. Mol Cancer Res. 2011; 9(7):925-35. DOI: 10.1158/1541-7786.MCR-10-0200. View